Type 2 Diabetes Mellitus in Adolescents From Southern India — A Single Center Experience

被引：0

作者：

Umamaheswari Gurunathan

Hemchand Krishna Prasad

Sherlin White

Thangavelu Sangalalingam

Nedunchelian Krishnamoorthy

机构：

[1] Mehta Multispeciality Hospitals India Pvt Ltd,Department of Pediatrics

来源：

Indian Pediatrics | 2021年 / 58卷

关键词：

Diabetic nephropathy; HbA1C; Outcome;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

This 1-year follow-up study was conducted on 21 subjects with type 2 diabetes mellitus. We found reduction in glycosylated hemoglobin from 10.5% to 8.1%, and maintenance of BMI z-scores from 3.9 to 3.8. Majority of the patients could be weaned-off from insulin. Heterogeneous presentation, frequent co-morbidities and complications, and familial clustering were observed.

引用

页码：176 / 177

页数：1

共 30 条

[1]

Bhatia V(2004)Etiology and outcome of childhood and adolescent diabetes mellitus is North India J Pediatr Endocrinol Metab. 17 993-9

[2]

Arya V(2016)Childhood and youth onset diabetes: A single center experience Indian J Pediatr 83 792-8

[3]

Dabadghao P(2017)Lipid profile in childhood-and youth-onset type 2 diabetes and their association with microvascular complications J Assoc Physicians India 65 42-47

[4]

Balasubramanian K(2015)Revised IAP Growth Charts for Height, Weight and Body Mass Index for 5- to 18-Year-Old Indian Children Indian Pediatr 52 47-55

[5]

Sharma K(2020)Impact of using different growth references on interpretation of anthropometric parameters of children aged 8–15 years Indian Pediatr 57 124-8

[6]

Jevalikar G(2018)ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 Diabetes Mellitus in Youth Pediatr Diabetes 19 28-46

[7]

Kohli C(2018)ISPAD Clinical Practice Consensus Guidelines 2018: The Diagnosis and Management of Monogenic Diabetes in Children and Adolescents Pediatr Diabetes 19 47-63

[8]

Bansal B(2018)ISPAD Clinical Practice Guidelines 2018: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State Pediatr Diabetes 19 155-77

[9]

Amutha A(2012)Metformin monotherapy in youth with recent onset type 2 diabetes: Experience from the prerandomization run-in phase of the TODAY study Pediatr Diabetes 13 369-75

[10]

Pradeepa R(2013)Safety and tolerability of the treatment of youth-onset type 2 diabetes: The TODAY experience Diabetes Care 36 1765-71.1

← 1 2 3 →